These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 31604943)

  • 1. HCMV-encoded US7 and US8 act as antagonists of innate immunity by distinctively targeting TLR-signaling pathways.
    Park A; Ra EA; Lee TA; Choi HJ; Lee E; Kang S; Seo JY; Lee S; Park B
    Nat Commun; 2019 Oct; 10(1):4670. PubMed ID: 31604943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human cytomegalovirus US7, US8, US9, and US10 are cytoplasmic glycoproteins, not found at cell surfaces, and US9 does not mediate cell-to-cell spread.
    Huber MT; Tomazin R; Wisner T; Boname J; Johnson DC
    J Virol; 2002 Jun; 76(11):5748-58. PubMed ID: 11992003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human cytomegalovirus-encoded US9 targets MAVS and STING signaling to evade type I interferon immune responses.
    Choi HJ; Park A; Kang S; Lee E; Lee TA; Ra EA; Lee J; Lee S; Park B
    Nat Commun; 2018 Jan; 9(1):125. PubMed ID: 29317664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of the Human Cytomegalovirus US16 Protein Abrogates Virus Entry into Endothelial and Epithelial Cells by Reducing the Virion Content of the Pentamer.
    Luganini A; Cavaletto N; Raimondo S; Geuna S; Gribaudo G
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28331097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptor 3 mediates a more potent antiviral response than Toll-like receptor 4.
    Doyle SE; O'Connell R; Vaidya SA; Chow EK; Yee K; Cheng G
    J Immunol; 2003 Apr; 170(7):3565-71. PubMed ID: 12646618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Cytomegalovirus UL111A and US27 Gene Products Enhance the CXCL12/CXCR4 Signaling Axis via Distinct Mechanisms.
    Tu CC; Arnolds KL; O'Connor CM; Spencer JV
    J Virol; 2018 Mar; 92(5):. PubMed ID: 29237840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Cytomegalovirus Tegument Protein UL82 Inhibits STING-Mediated Signaling to Evade Antiviral Immunity.
    Fu YZ; Su S; Gao YQ; Wang PP; Huang ZF; Hu MM; Luo WW; Li S; Luo MH; Wang YY; Shu HB
    Cell Host Microbe; 2017 Feb; 21(2):231-243. PubMed ID: 28132838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transmembrane Protein pUL50 of Human Cytomegalovirus Inhibits ISGylation by Downregulating UBE1L.
    Lee MK; Kim YJ; Kim YE; Han TH; Milbradt J; Marschall M; Ahn JH
    J Virol; 2018 Aug; 92(15):. PubMed ID: 29743376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Cytomegalovirus DNA Polymerase Subunit UL44 Antagonizes Antiviral Immune Responses by Suppressing IRF3- and NF-κB-Mediated Transcription.
    Fu YZ; Su S; Zou HM; Guo Y; Wang SY; Li S; Luo MH; Wang YY
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30867312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. U
    Goodwin CM; Schafer X; Munger J
    J Virol; 2019 Dec; 93(23):. PubMed ID: 31534044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptors and immune sensors: the complex entry path of human cytomegalovirus.
    Compton T
    Trends Cell Biol; 2004 Jan; 14(1):5-8. PubMed ID: 14729174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of a US7/US8/UL23/US3-deleted recombinant pseudorabies virus and evaluation of its pathogenicity in dogs.
    Yin H; Li Z; Zhang J; Huang J; Kang H; Tian J; Qu L
    Vet Microbiol; 2020 Jan; 240():108543. PubMed ID: 31902487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human cytomegalovirus-encoded US2 differentially affects surface expression of MHC class I locus products and targets membrane-bound, but not soluble HLA-G1 for degradation.
    Barel MT; Ressing M; Pizzato N; van Leeuwen D; Le Bouteiller P; Lenfant F; Wiertz EJ
    J Immunol; 2003 Dec; 171(12):6757-65. PubMed ID: 14662880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The E3 ubiquitin ligase RNF182 inhibits TLR-triggered cytokine production through promoting p65 ubiquitination and degradation.
    Cao Y; Sun Y; Chang H; Sun X; Yang S
    FEBS Lett; 2019 Nov; 593(22):3210-3219. PubMed ID: 31432514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TLR signaling pathways.
    Takeda K; Akira S
    Semin Immunol; 2004 Feb; 16(1):3-9. PubMed ID: 14751757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-like receptor (TLR)-mediated innate immune responses in the control of hepatitis B virus (HBV) infection.
    Zhang E; Lu M
    Med Microbiol Immunol; 2015 Feb; 204(1):11-20. PubMed ID: 25550115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human cytomegalovirus US7 is regulated synergistically by two virally encoded microRNAs and by two distinct mechanisms.
    Tirabassi R; Hook L; Landais I; Grey F; Meyers H; Hewitt H; Nelson J
    J Virol; 2011 Nov; 85(22):11938-44. PubMed ID: 21900172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in TLRs as new molecular markers of congenital infections with Human cytomegalovirus?
    Wujcicka W; Wilczyński J; Nowakowska D
    Pathog Dis; 2014 Feb; 70(1):3-16. PubMed ID: 23929630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The poxvirus protein A52R targets Toll-like receptor signaling complexes to suppress host defense.
    Harte MT; Haga IR; Maloney G; Gray P; Reading PC; Bartlett NW; Smith GL; Bowie A; O'Neill LA
    J Exp Med; 2003 Feb; 197(3):343-51. PubMed ID: 12566418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.